MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway

BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lack of effective therapeutic options. Early diagnosis and prognosis of ICC by non...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Exp Clin Cancer Res
Autors principals: Li, Jian-Hui, Zhu, Xiao-Xu, Li, Fu-Xi, Huang, Chen-Song, Huang, Xi-Tai, Wang, Jie-Qin, Gao, Zhuo-Xing, Li, Shi-Jin, Xu, Qiong-Cong, Zhao, Wei, Yin, Xiao-Yu
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6882185/
https://ncbi.nlm.nih.gov/pubmed/31775892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1477-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars